NO753690L - - Google Patents
Info
- Publication number
- NO753690L NO753690L NO753690A NO753690A NO753690L NO 753690 L NO753690 L NO 753690L NO 753690 A NO753690 A NO 753690A NO 753690 A NO753690 A NO 753690A NO 753690 L NO753690 L NO 753690L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- compounds
- stands
- group
- pyridyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- BYLPZVAKOZYZPH-UHFFFAOYSA-N imidazo[2,1-a]isoquinoline Chemical class C1=CC=C2C3=NC=CN3C=CC2=C1 BYLPZVAKOZYZPH-UHFFFAOYSA-N 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000000935 antidepressant agent Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- CSNXUYRHPXGSJD-UHFFFAOYSA-N isoquinolin-5-ol Chemical compound N1=CC=C2C(O)=CC=CC2=C1 CSNXUYRHPXGSJD-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical class [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- -1 β-pyridine carboxylic acid methyl ester Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52314174A | 1974-11-12 | 1974-11-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO753690L true NO753690L (es) | 1976-05-13 |
Family
ID=24083820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO753690A NO753690L (es) | 1974-11-12 | 1975-11-04 |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5170799A (es) |
| AU (1) | AU8656175A (es) |
| BE (1) | BE835446A (es) |
| DD (1) | DD122682A5 (es) |
| DE (1) | DE2549088A1 (es) |
| DK (1) | DK494275A (es) |
| ES (1) | ES442490A1 (es) |
| FI (1) | FI753070A (es) |
| FR (1) | FR2290901A1 (es) |
| NL (1) | NL7513061A (es) |
| NO (1) | NO753690L (es) |
| SE (1) | SE7512323L (es) |
| ZA (1) | ZA757124B (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1258946A (es) * | 1969-05-06 | 1971-12-30 | ||
| US3624093A (en) * | 1970-03-10 | 1971-11-30 | American Home Prod | 5,6-disubstituted-2,3,5,6-tetrahydroimidazo-{8 2,1-{60 {9 isoquinolin-6-ols |
| DE2460527A1 (de) * | 1974-01-02 | 1975-07-10 | Sandoz Ag | Neue organische verbindungen und verfahren zu deren herstellung |
-
1975
- 1975-11-03 FI FI753070A patent/FI753070A/fi not_active Application Discontinuation
- 1975-11-03 DE DE19752549088 patent/DE2549088A1/de active Pending
- 1975-11-03 DK DK494275A patent/DK494275A/da unknown
- 1975-11-04 NO NO753690A patent/NO753690L/no unknown
- 1975-11-04 SE SE7512323A patent/SE7512323L/xx unknown
- 1975-11-07 NL NL7513061A patent/NL7513061A/xx unknown
- 1975-11-10 JP JP50134194A patent/JPS5170799A/ja active Pending
- 1975-11-10 BE BE161757A patent/BE835446A/xx unknown
- 1975-11-10 ES ES442490A patent/ES442490A1/es not_active Expired
- 1975-11-11 DD DD189396A patent/DD122682A5/xx unknown
- 1975-11-12 ZA ZA757124A patent/ZA757124B/xx unknown
- 1975-11-12 AU AU86561/75A patent/AU8656175A/en not_active Expired
- 1975-11-12 FR FR7534456A patent/FR2290901A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2549088A1 (de) | 1976-05-13 |
| FR2290901B1 (es) | 1978-07-28 |
| SE7512323L (sv) | 1976-05-13 |
| BE835446A (fr) | 1976-05-10 |
| JPS5170799A (en) | 1976-06-18 |
| FI753070A (es) | 1976-05-13 |
| ZA757124B (en) | 1977-06-29 |
| FR2290901A1 (fr) | 1976-06-11 |
| NL7513061A (nl) | 1976-05-14 |
| DK494275A (da) | 1976-05-13 |
| DD122682A5 (es) | 1976-10-20 |
| ES442490A1 (es) | 1977-05-16 |
| AU8656175A (en) | 1977-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3476883B2 (ja) | ヘテロ環含有カルボン酸誘導体 | |
| US3853915A (en) | 9-or 10-halo-4h-benzo{8 4,5{9 cyclo-hepta{8 1,2-b{9 thiophen-4-ones | |
| KR100303737B1 (ko) | 피페라진유도체 | |
| SU428597A3 (ru) | СПОСОБ ПОЛУЧЕНИЯ р-АРИЛ-2-АМИНОАЛКОКСИСТИРОЛОВ | |
| EP0674619A1 (en) | Tryptamine analogues as 5-ht 1?-like agonists | |
| DK162629B (da) | 2-substituerede 1-aralkyl-imidazoler og farmaceutiske midler der indeholder disse, anvendelse heraf til fremstilling af farmaceutiske midler samt fremgangsmaade til fremstilling heraf | |
| ZA200602694B (en) | Process for the preparation of N-amino substituted heterocyclic compounds | |
| SK3202003A3 (en) | Method for the preparation of citalopram, citalopram prepared by this method and pharmaceutical composition comprising same | |
| NO840329L (no) | Fremgangsmaate for fremstilling av 4-cyanopyridazin-derivater. | |
| CN103025715A (zh) | 用于制备凝血酶特异性抑制剂的中间体和方法 | |
| Ma et al. | Synthesis of 1, 2-dihydro-4H-3, 1-benzoxazine derivatives via ZnCl2 catalyzed cyclocondensation reaction | |
| CN109467532B (zh) | 4-三氟甲基烟酸的制备方法 | |
| KR890000706B1 (ko) | 1,6-나프티리딘 유도체의 제조방법 | |
| NO753690L (es) | ||
| GB2204037A (en) | N-substituted 4-hydroxypyridine-3-carboxamides | |
| SU1033003A3 (ru) | Способ получени производных 4-пиримидона или их фармацевтически приемлемых кислотно-аддитивных солей | |
| KR900003497B1 (ko) | 퀴나졸린디온 및 피리도피리미딘디온 및 이들을 함유하는 제약 조성물 | |
| US4100165A (en) | Imidazo [2,1-a]isoquinolines | |
| NO860048L (no) | Octahydroindolizin-forbindelser med analgetisk virkning. | |
| NO744667L (es) | ||
| US4087433A (en) | 1,5,10,11-Tetrahydrobenzo[4,5]-cyclohepta[1,2-b]pyrazolo[4,3-e]pyridines | |
| US4059586A (en) | 5-Alkoxy-2-alkyl-1,2,3,4-tetrahydroisoquinolene-8-carboxaldehyde and derivatives | |
| NO125530B (es) | ||
| JPH01203379A (ja) | さらに水素化された１―ベンゾオキサシクロアルキルピリジンカルボン酸類 | |
| NO164934B (no) | Fremgangsmaate for maaling av trykk ved perforering av en foring i et borehull. |